A new deep-learning AI algorithm significantly lowered false positives in lung nodule malignancy assessment while maintaining high detection rates.
Key Details
- 1Deep-learning algorithm estimated lung nodule malignancy risk using LDCT data.
- 2Trained on 16,077 nodules (1,249 malignant) from the NLST; validated on a pooled cohort of 4,146 participants and 7,794 nodules.
- 3AUC for AI model was equal or superior to PanCan: ~0.98 (1yr), 0.96 (2yr) in pooled cohort; up to 0.95 for indeterminate nodules.
- 4For size-matched nodules, AI model AUC was 0.79 vs. PanCan at 0.6.
- 5At 100% sensitivity for cancer, AI flagged 68.1% of benign nodules as low-risk vs. PanCan's 47.4% (39.4% relative reduction in false positives).
- 6Authors stress the need for prospective clinical validation before routine use.
Why It Matters
Reducing false positives in lung cancer screening can minimize unnecessary procedures, patient anxiety, and healthcare costs. Improved AI-based risk stratification stands to improve the efficiency and effectiveness of LDCT lung cancer screening programs.
Source
AuntMinnie
Related News
•AuntMinnie
Multimodal LLMs Show Improved Performance on Japanese Radiology Board Exams
New multimodal large language models (LLMs) like OpenAI o3 and Gemini 2.5 Pro demonstrated significant advancements in answering Japanese radiology board exam questions, particularly with image input.
•Health Imaging
AI Surpasses Radiologists in Predicting Lung Cancer Treatment Response
AI demonstrates higher accuracy than radiologists in predicting lung cancer treatment response from imaging.
•Radiology Business
Medicare Denies Over Half of Radiology AI Claims, Study Finds
Medicare denied $16 million in radiology AI claims between 2018 and 2023, rejecting over half submitted.